CHASE has retained Silver Medal status from the global business sustainability index, EcoVadis. This places us in the top 25% of companies worldwide for sustainability and we’re delighted to have improved our score from last time.
At CHASE, we have made a commitment to minimise our footprint by examining and improving four key areas set out by EcoVadis; environmental impact, labour and human rights standards, ethics, and sustainable procurement practices.
On the award, CHASE CEO, Graham Hawthorn said, “We are thrilled to have been recognised by EcoVadis for our continued drive towards being a more sustainable business. Our core value of treating everyone with respect and integrity extends beyond our interactions with clients to our impact on the world around us.”
We take our impact on the environment and people around us seriously, and EcoVadis was a natural step to help us meet our sustainability goals.

EcoVadis is the world’s most trusted sustainability ratings organisation. It helps businesses create visibility on ESG risk and compliance allowing companies to meet sustainability goals and drive impact at scale.
Since its inception in 2007, EcoVadis has grown to become the most recognisable provider of business sustainability audits. EcoVadis helped almost 100,000 companies across 160 countries, and 200 industries improve their global footprints, including; L’Oreal, LVMH, Salesforce and BASF.
At CHASE, we believe we have an obligation to improve the environmental and social impacts of our business.
“The EcoVadis process has really helped us focus on what’s important. We’re making good progress, but we’re committed to continuous improvement across our Group companies.” said Graham Hawthorn.
To achieve a silver medal status, CHASE was evaluated on 21 sustainability criteria across the four key areas of Environment, Labour & Human Rights, Ethics, and Sustainable Procurement.
Each of the 21 criteria is scored on seven key principles, split between the company being assessed and commitments by EcoVadis to ensure the validity of their process:
This post was first published in 2023.
Explore our latest thinking, event updates and industry insights to stay informed.

Kent and Medway has signed the first local variation of the PCN DES, worth £10 million a year. CHASE assesses what the framework still leaves unsettled.

From April 2027, NHS Carbon Reduction Plan rules demand full scope 3 emissions data. CHASE assesses what this means for pharma and medtech suppliers.

Yvette Cooper is the UK's new health secretary after a reshuffle that also reshaped the medtech brief. Here's what it means for pharma, medtech and NHS teams.